State-of-the-Art Biorepository
NexGen is a state-of-the art, College of American Pathologists (CAP) accredited biorepository founded in 2019 with a mission to provide life cycle management services of biological specimens to the life science ecosystem.
Leadership Team
As a leader in biospecimen storage and supply chain solutions, NexGen provides full life-cycle management in support of academic, government, biotechnology, pharmaceutical, and healthcare institutions to enhance research and clinical outcomes.
Managing Partner
Former Vice President and General Manager of a global cryogenic equipment services business. Active member of International Society for Biological & Environmental Repositories (ISBER); Chairperson, Atlanta Community Task Force for 2022 Global Annual Meeting in Atlanta; Co-Chair 2019 ISBER Annual Meeting in Shanghai, China. Previously served on ISBER’s Nominating Committee, Site Location Task Force, and Organizing Advisory Committee.
Partner
Former owner and founder of a bulk gas distributor of specialty, medical, and industrial gases and provider of life science cold chain solutions in the Atlanta Metropolitan area.
Former owner of a commercial biobank serving academic, healthcare, and clinical research clients located in the Research Triangle area of North Carolina.
Vice President & General Manager
Executive with broad experience in all aspects of product, operational and financial management.
Focused on Life Science and Health Care markets with extensive experience in sample management and cold storage across key segments – biomedical R&D, biotechnology and pharmaceutical.
MT (ASCP), Biorepository Director
Executive with expertise in management, operations, and compliance supporting clinical laboratories and biobanks. Lead Regulatory Compliance including CLIA/CAP accreditation, GCP compliance, and multi-state licensure.
Leads NexGen’s biorepository operations, compliance, and management.
Director of Scientific Operations
Biotechnology cross-functional leader supporting scientific operations with extensive cell and molecular biology expertise including biologics, cell, and gene therapies.
Leads NexGen’s scientific and laboratory operations for biospecimen life cycle management.
Advisory Board of Directors
Board of Directors
Corporate Executive and Scientist in academia and pharma with a track record in molecular biology, genetics, biomarker development, biobanking, laboratory and project leadership. Currently President of Allai Health. Formerly was co-founder of Akesogen, Director of Center for Medical Genomic at Emory University, Director at GlaxoSmithKline, and Genetics and Senior Scientist at UK Cancer Research.
Board of Directors
Corporate Executive with a track record in private equity, mergers and acquisitions, and corporate liquidity management sales. Originated and closed 50+ investments into businesses and deployed over $1.5B capital. Currently Founder and Managing Partner at Oceanrock Capital and Board Member of IC Biomedical. Formerly was Partner and Principal with The Riverside Company and Raymond James Capital.
Board of Directors
Corporate board member with strong experience in mergers and acquisitions, international business, business development and business planning. Currently on Boards of Directors with Antylia Scientific (formerly Cole-Palmer), Klatu Networks, FEI Inc., IC Biomedical and Nordon Plastic. Formerly CEO Environmental Express, President Kendro Laboratory Products (division SPX), Executive Vice President & Chief Operating Officer Cole-Palmer, and Vice President Sales & Customer Service Fisher Scientific.
